These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7847660)

  • 1. Castleman disease and renal amyloidosis.
    Kazes I; Deray G; Jacobs C
    Ann Intern Med; 1995 Mar; 122(5):395-6. PubMed ID: 7847660
    [No Abstract]   [Full Text] [Related]  

  • 2. Castleman's disease with renal amyloidosis and nephrotic syndrome.
    Arinsoy T; Yilmaz M; Ataoğlu O; Bali M; Sindel S
    Nephrol Dial Transplant; 1997 Dec; 12(12):2713-6. PubMed ID: 9430878
    [No Abstract]   [Full Text] [Related]  

  • 3. [Highly thrombogenic forms of Behçet's disease associated with Castleman's disease and renal amyloidosis].
    Belgnaoui F; Raki S; Douira L; Benabdellah L; Rimani M; Labraïmi A; Aouni M; Senouci K; Hassam B
    Ann Dermatol Venereol; 2006 Mar; 133(3):278-80. PubMed ID: 16800185
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistently elevated inflammatory markers and marked proteinuria due to Castleman disease.
    Jagiełło W; Milewski M; Gałązka K; Budzyński A; Musiał J
    Pol Arch Med Wewn; 2015; 125(12):952-3. PubMed ID: 26787634
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary (AA) amyloidosis associated with Castleman's disease. Report of two cases and review of the literature.
    Ordi J; Grau JM; Junqué A; Nomdedeu B; Palacin A; Cardesa A
    Am J Clin Pathol; 1993 Oct; 100(4):394-7. PubMed ID: 8213634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Castleman's disease with nephrotic syndrome, amyloidosis and autoimmune manifestations.
    Curioni S; D'Amico M; Quartagno R; Martino S; Dell'Antonio G; Cusi D
    Nephrol Dial Transplant; 2001 Jul; 16(7):1475-8. PubMed ID: 11427644
    [No Abstract]   [Full Text] [Related]  

  • 7. Castleman disease with renal amyloidosis: imaging findings and clinical significance.
    Moon WK; Kim SH; Im JG; Yeon KM; Han MC
    Abdom Imaging; 1995; 20(4):376-8. PubMed ID: 7549748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentric Castleman disease with secondary AA renal amyloidosis, nephrotic syndrome and chronic renal failure, remission after high-dose melphalan and autologous stem cell transplantation.
    Ogita M; Hoshino J; Sogawa Y; Sawa N; Katori H; Takemoto F; Ubara Y; Hara S; Miyakoshi S; Takaichi K
    Clin Nephrol; 2007 Sep; 68(3):171-6. PubMed ID: 17915620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-stage renal failure from renal amyloidosis of the AA type associated with giant lymph node hyperplasia (Castleman's disease).
    Montoli A; Minola E; Stabile F; Grillo C; Radaelli L; Spanti D; Luccarelli E; Spata C; Minetti L
    Am J Nephrol; 1995; 15(2):142-6. PubMed ID: 7733151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of nephrotic syndrome with colchicine therapy secondary to amyloidosis with associated Castleman's disease.
    Paydas S; Gonlusen G; Sagliker Y
    Nephron; 1995; 71(4):463-4. PubMed ID: 8587630
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiofollicular lymph node hyperplasia with amyloidosis.
    West KP; Morgan DR; Lauder I
    Postgrad Med J; 1989 Feb; 65(760):108-11. PubMed ID: 2780459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal diarrhea in a patient with Castleman's disease associated with intestinal amyloidosis.
    Miura A; Sato I; Suzuki C
    Intern Med; 1995 Nov; 34(11):1106-9. PubMed ID: 8774974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
.
    Yamada Y; Ueno T; Irifuku T; Nakashima A; Doi S; Ichinohe T; Masaki T
    Clin Nephrol; 2018 Sep; 90(3):232-236. PubMed ID: 29701172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary amyloidosis associated with Castleman's disease.
    Tanaka K; Horita M; Shibayama H; Seike M; Itoh Y; Hamaguchi K; Sato Y; Sakata T; Ishida T
    Intern Med; 1995 Feb; 34(2):122-6. PubMed ID: 7727877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotic syndrome associated with angiofollicular lymph node hyperplasia, and subsequent amyloidosis.
    Chan KW; Lo WK; Cheng IK
    Pathology; 1992 Jul; 24(3):229-30. PubMed ID: 1437301
    [No Abstract]   [Full Text] [Related]  

  • 16. Recovery from AA amyloidosis-cardiomyopathy complexed with unicentric Castleman disease.
    Imamura K; Kojima S; Imamura T; Tsujita K
    BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 35981748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report of six kidney disease-associated Castleman's disease cases.
    Sui Y; Zhao D
    Clin Nephrol; 2015 Dec; 84(6):344-52. PubMed ID: 26445003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia associated with increased hepcidin in two children with Castleman disease.
    Mizukami M; Yoto Y; Nishihori S; Kimura S; Tsutsumi H
    Pediatr Int; 2018 Sep; 60(9):882-884. PubMed ID: 30187597
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphadenopathy and proteinuria.
    Karie S; Izzedine H; Beaufils H; Charlotte F; Launay-Vacher V; Deray G
    Nephrol Dial Transplant; 2004 Mar; 19(3):739-41. PubMed ID: 14767037
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac tamponade secondary to giant lymph node hyperplasia. Castleman's disease.
    Shahidi H; Kvale PA
    Chest; 1995 Feb; 107(2):581. PubMed ID: 7710518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.